NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (generally accepted accounting principles) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been
included. The results of operations for the three and nine month periods ended February 29, 2016 are not necessarily indicative of the results to be expected for the fiscal year ending May 31, 2016. For more complete financial information,
these consolidated financial statements should be read in conjunction with the May 31, 2015 audited consolidated financial statements and the notes thereto included in the Companys annual report on Form 10-K for the year ended
May 31, 2015.
2. INVENTORIES
Inventories are stated at the lower of cost, determined on the first-in, first-out method, or market. The components of inventories follow:
|
|
|
|
|
|
|
|
|
|
|
February 29,
2016
|
|
|
May 31,
2015
|
|
|
|
(In thousands)
|
|
Raw Materials
|
|
$
|
27,874
|
|
|
$
|
21,605
|
|
Work-in-process
|
|
|
5,019
|
|
|
|
3,972
|
|
Finished and purchased goods
|
|
|
32,555
|
|
|
|
26,024
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
65,448
|
|
|
$
|
51,601
|
|
|
|
|
|
|
|
|
|
|
3. NET INCOME PER SHARE
The calculation of net income per share attributable to Neogen Corporation follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
February 29/28,
|
|
|
Nine Months Ended
February 29/28,
|
|
|
|
2016
|
|
|
2015
|
|
|
2016
|
|
|
2015
|
|
|
|
(In thousands, except per share amounts)
|
|
Numerator for basic and diluted net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income attributable to Neogen shareholders
|
|
$
|
8,311
|
|
|
$
|
7,454
|
|
|
$
|
26,707
|
|
|
$
|
24,142
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares
|
|
|
37,473
|
|
|
|
37,006
|
|
|
|
37,358
|
|
|
|
36,907
|
|
Effect of dilutive stock options and warrants
|
|
|
485
|
|
|
|
530
|
|
|
|
500
|
|
|
|
492
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for diluted net income per share
|
|
|
37,958
|
|
|
|
37,536
|
|
|
|
37,858
|
|
|
|
37,399
|
|
Net income attributable to Neogen Corporation per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.22
|
|
|
$
|
0.20
|
|
|
$
|
0.71
|
|
|
$
|
0.65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
0.22
|
|
|
$
|
0.20
|
|
|
$
|
0.71
|
|
|
$
|
0.65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7
4. SEGMENT INFORMATION
The Company has two reportable segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits
and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products
dedicated to animal health, including a complete line of consumable products marketed to veterinarians and animal health product distributors; the segment also provides genetic identification services. Additionally, Animal Safety produces and
markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.
Segment information as of and for the three months ended February 29/28, 2016 and 2015 follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food
Safety
|
|
|
Animal
Safety
|
|
|
Corporate and
Eliminations
(1)
|
|
|
Total
|
|
|
|
(In thousands)
|
|
Fiscal 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product revenues to external customers
|
|
$
|
31,975
|
|
|
$
|
32,402
|
|
|
$
|
0
|
|
|
$
|
64,377
|
|
Service revenues to external customers
|
|
|
2,623
|
|
|
|
9,725
|
|
|
|
0
|
|
|
|
12,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues to external customers
|
|
|
34,598
|
|
|
|
42,127
|
|
|
|
0
|
|
|
|
76,725
|
|
Operating income (loss)
|
|
|
6,114
|
|
|
|
6,149
|
|
|
|
(1,009
|
)
|
|
|
11,254
|
|
Total assets
|
|
|
130,077
|
|
|
|
189,191
|
|
|
|
112,973
|
|
|
|
432,241
|
|
Fiscal 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product revenues to external customers
|
|
$
|
29,348
|
|
|
$
|
28,718
|
|
|
$
|
0
|
|
|
$
|
58,066
|
|
Service revenues to external customers
|
|
|
2,617
|
|
|
|
7,726
|
|
|
|
0
|
|
|
|
10,343
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues to external customers
|
|
|
31,965
|
|
|
|
36,444
|
|
|
|
0
|
|
|
|
68,409
|
|
Operating income (loss)
|
|
|
6,976
|
|
|
|
6,087
|
|
|
|
(903
|
)
|
|
|
12,160
|
|
Total assets
|
|
|
108,993
|
|
|
|
178,685
|
|
|
|
90,757
|
|
|
|
378,435
|
|
Segment information for the nine months ended February 29/28, 2016 and 2015 follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food
Safety
|
|
|
Animal
Safety
|
|
|
Corporate and
Eliminations
(1)
|
|
|
Total
|
|
|
|
(In thousands)
|
|
Fiscal 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
Product revenues to external customers
|
|
$
|
98,708
|
|
|
$
|
99,423
|
|
|
$
|
0
|
|
|
$
|
198,131
|
|
Service revenues to external customers
|
|
|
7,604
|
|
|
|
25,461
|
|
|
|
0
|
|
|
|
33,065
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues to external customers
|
|
|
106,312
|
|
|
|
124,884
|
|
|
|
0
|
|
|
|
231,196
|
|
Operating income (loss)
|
|
|
22,222
|
|
|
|
21,322
|
|
|
|
(2,783
|
)
|
|
|
40,761
|
|
Fiscal 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product revenues to external customers
|
|
$
|
87,761
|
|
|
$
|
88,353
|
|
|
$
|
0
|
|
|
$
|
176,114
|
|
Service revenues to external customers
|
|
|
8,122
|
|
|
|
20,227
|
|
|
|
0
|
|
|
|
28,349
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues to external customers
|
|
|
95,883
|
|
|
|
108,580
|
|
|
|
0
|
|
|
|
204,463
|
|
Operating income (loss)
|
|
|
22,688
|
|
|
|
18,228
|
|
|
|
(2,420
|
)
|
|
|
38,496
|
|
(1)
|
Includes corporate assets, consisting principally of cash and cash equivalents, marketable securities, deferred assets and overhead expenses not allocated to specific business segments. Also includes the elimination of
intersegment transactions.
|
8
5. EQUITY COMPENSATION PLANS
Options are generally granted under the employee and director stock option plan for five-year periods and become exercisable in equal annual
installments during that period. Certain non-qualified options are granted for ten-year periods. A summary of stock option activity during the nine months ended February 29, 2016 follows:
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
Weighted-
Average
Exercise Price
|
|
Options outstanding at June 1, 2015
|
|
|
1,988,000
|
|
|
$
|
31.04
|
|
Granted
|
|
|
549,000
|
|
|
|
46.98
|
|
Exercised
|
|
|
(385,000
|
)
|
|
|
23.45
|
|
Forfeited
|
|
|
(19,000
|
)
|
|
|
36.62
|
|
|
|
|
|
|
|
|
|
|
Options outstanding at February 29, 2016
|
|
|
2,133,000
|
|
|
|
36.47
|
|
During the three and nine month periods ended February 29/28, 2016 and 2015 the Company recorded $1,462,000 and $1,228,000 and
$4,007,000 and $3,187,000 of compensation expense related to its share-based awards.
The weighted-average fair value of stock options granted during
fiscal 2016 and fiscal 2015, estimated on the date of grant using the Black-Scholes option pricing model was $13.11 and $11.91, respectively, per option. The fair value of stock options granted was estimated using the following weighted-average
assumptions.
|
|
|
|
|
|
|
FY2016
|
|
FY2015
|
Risk-free interest rate
|
|
1.2%
|
|
1.2%
|
Expected dividend yield
|
|
0%
|
|
0%
|
Expected stock price volatility
|
|
33.3%
|
|
36.2%
|
Expected option life
|
|
4.0 years
|
|
4.0 years
|
The Company has an Employee Stock Purchase plan that provides for employee stock purchases at a 5% discount to market price.
The discount is recorded in administrative expense as of the date of purchase.
6. NEW ACCOUNTING PRONOUNCEMENTS
In May 2014, the FASB issued a new standard on revenue recognition. The new standard outlines a single comprehensive model for entities to
use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the revenue model is that an entity should recognize revenue to
depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard is designed to create greater comparability
for financial statement users across industries and jurisdictions and also requires enhanced disclosures. The guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption is not
permitted. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.
The FASB recently
issued ASU 2015-17 as part of its Simplification Initiative. The amendments eliminate the guidance in Topic 740,
Income Taxes
, that required an entity to separate deferred tax liabilities and assets between current and noncurrent amounts in a
classified balance sheet. Rather, deferred taxes will be presented as noncurrent under the new standard. It takes effect in 2017 for public companies and early adoption is permitted.
7. BUSINESS AND PRODUCT LINE ACQUISITIONS
The Consolidated Statements of Income reflect the results of operations for business acquisitions since the respective dates of purchase.
All are accounted for using the acquisition method. Goodwill recognized in the acquisitions discussed below relates primarily to enhancing the Companys strategic platform for the expansion of available product offerings.
On July 1, 2013, the Company acquired the assets of SyrVet Inc., a veterinary business based in Waukee, Iowa. SyrVet offered a product line similar to
Neogens Ideal Instruments line of veterinary instruments with a strong presence in Mexico and Latin America. Consideration for the purchase was $10,012,000 in cash and up to $1,500,000 of a contingent consideration liability, due at the end of
the first year, based on an excess net sales formula. The Company estimated the contingent consideration liability to be $930,000, based on forecasted sales. The final purchase price allocation, based upon the fair value of these assets determined
using the income
9
approach, included accounts receivable of $747,000, net inventory of $2,195,000, property and equipment of $556,000, current liabilities of $226,000, contingent consideration liabilities of
$930,000, non-amortizable trademarks of $790,000, intangible assets of $4,810,000 (with an estimated life of 15 years) and the remainder to goodwill (deductible for tax purposes). These values are Level 3 fair value measurements. This business has
been relocated to Lexington, Kentucky and integrated with the Companys current operations there, reporting within the Animal Safety segment. In August 2014, the Company paid $689,000 to the former owner for contingent consideration based upon
the level of achievement of sales targets; the remaining $241,000 of the accrual was reversed to other income.
On November 1, 2013, the Company acquired
the assets of Prima Tech Incorporated, a veterinary instrument company based in Kenansville, North Carolina. Prima Tech manufactures devices used by farmers, ranchers, and veterinarians to inject animals, provide topical applications, and to use for
oral administration. Prima Tech is also a supplier of products used in artificial insemination in the swine industry. Consideration for the purchase was $12,068,000 in cash and up to $600,000 of contingent consideration, due at the end of the first
year, based on an excess net sales formula. The Company estimated the contingent consideration liability to be $146,000 based on forecasted sales. The final purchase price allocation, based upon the fair value of these assets determined using the
income approach, included accounts receivable of $963,000, net inventory of $2,796,000, property and equipment of $1,653,000, prepaid assets of $8,000, current liabilities of $1,840,000, contingent consideration liabilities of $146,000,
non-amortizable trademarks of $1,500,000, intangible assets of $4,400,000 (with an estimated life of 5-15 years) and the remainder to goodwill (deductible for tax purposes). These values are Level 3 fair value measurements. This business continues
to operate in its current location and reports within the Animal Safety segment. In October 2014, the Company paid the former owners $600,000 for contingent consideration based on achievement of defined sales targets, recording an additional
$454,000 charge to other expense.
On January 2, 2014, the Company acquired all of the stock of Chem-Tech Ltd., a pest control manufacturing and
distribution business located in Pleasantville, Iowa. Consideration for the purchase was $17,185,000 in cash and up to $1,000,000 of a contingent consideration liability, due at the end of the first year, based on an excess net sales formula. The
Company estimated the contingent consideration liability to be $390,000, based on forecasted sales. The final purchase price allocation included accounts receivable of $380,000, net inventory of $4,184,000, prepaid assets of $100,000, property and
equipment of $807,000, current liabilities of $184,000, contingent consideration liabilities of $390,000, intangible assets of $8,327,000 (with an estimated life of 5-25 years) and the remainder to goodwill (deductible for tax purposes). These
values are Level 3 fair value measurements. This business continues to operate in its current location and reports within the Animal Safety segment. In February 2015, the Company paid the former owners $474,000 for contingent consideration
based upon achievement of sales targets, recording an additional $84,000 charge to other expense.
On October 1, 2014, the Company acquired all of the
stock of BioLumix, Inc., a manufacturer and marketer of automated systems for the detection of microbial contaminants located in Ann Arbor, Michigan. Consideration for the purchase was $4,514,000 in cash. The final purchase price allocation included
accounts receivable of $499,000, other receivable of $178,000, net inventory of $421,000 prepaid assets of $48,000, property and equipment of $159,000, current liabilities of $155,000, long-term liabilities of $780,000, intangible assets of
$2,090,000 (with an estimated life of 5-15 years) and the remainder to goodwill (non-deductible for tax purposes). These values are Level 3 fair value measurements. This business has been relocated to Lansing, Michigan and integrated with the
Companys operations there, reporting within the Food Safety segment.
On December 8, 2014, the Company acquired the food safety and veterinary
genomic assets of its Chinese distributor Beijing Anapure BioScientific Co., Ltd. Consideration for the purchase was $2,040,000 in cash. The final purchase price allocation included inventory of $525,000, property and equipment of $64,000,
intangible assets of $422,000 (with an estimated life of 5-15 years) and the remainder to goodwill. These values are Level 3 fair value measurements. This business has been integrated into the Companys subsidiary in China and reports within
the Food Safety segment.
On June 1, 2015, Neogen acquired the assets of Sterling Test House, a commercial food testing laboratory based in
India. Consideration for the purchase was $1,118,000 in cash and approximately $150,000 of a contingent consideration liability, due in installments on the first two anniversary dates, based on an excess sales formula. The preliminary purchase
price allocation included accounts receivable of $43,000, net inventory of $14,000, property and equipment of $141,000 and the remainder to goodwill and other intangible assets. These values are Level 3 fair value measurements. This business
continues to operate in its current location and reports within the Animal Safety segment.
On August 26, 2015, the Company acquired all of the stock of
Lab M Holdings, a developer, manufacturer and supplier of microbiological culture media and diagnostic systems located in the United Kingdom. Consideration for the purchase was $12,436,000 in cash. The preliminary purchase price allocation included
cash of $285,000, accounts receivable of $975,000, net inventory of $1,169,000, property and equipment of $3,337,000, other current assets of $596,000, current liabilities of $1,350,000, long-term deferred tax liability of $784,000, intangible
assets of $3,918,000 (with an estimated life of 3-15 years) and the remainder to goodwill. These values are Level 3 fair value measurements. This business will continue to operate in its current location and reports within the Food Safety segment.
10
On December 22, 2015, the Company acquired the rodenticide assets of Virbac Corporation, the North American
affiliate of the France-based Virbac group, a global animal health company. The acquired assets include a rodenticide active ingredient that complements Neogens existing active ingredients, and more than 40 regulatory approvals for a variety
of formulations in the United States, Canada and Mexico. The acquired assets also include a large retail and OEM customer base. Consideration for the purchase was $3,525,000 in cash and up to $300,000 of contingent consideration. The preliminary
purchase price allocation included inventory of $317,000, property and equipment of $60,000, intangible assets of $2,545,000 (with an estimated life of 5-15 years) and the remainder to goodwill (deductible for tax purposes). These values are Level 3
fair value measurements. The products will be manufactured at the Companys current production facility in Randolph, Wisconsin and will report through Animal Safety.
8. LONG TERM DEBT
The Company has a financing agreement with a bank providing for an unsecured revolving line of credit of $12,000,000, which matures on
September 1, 2017. There were no advances against this line of credit during fiscal 2016 and fiscal 2015 and no balance outstanding at February 29, 2016. Interest is at LIBOR plus 100 basis points (rate under the terms of the agreement was
1.18% at February 29, 2016). Financial covenants include maintaining specified levels of tangible net worth, debt service coverage, and funded debt to EBITDA, each of which the Company was in compliance with at February 29, 2016.
9. COMMITMENTS AND CONTINGENCIES
The Company is involved in environmental remediation and monitoring activities at its Randolph, Wisconsin manufacturing facility and accrues
for related costs when such costs are determined to be probable and estimable. The Company is currently expensing annual costs of remediation, which have ranged from $47,000 to $56,000 per year over the past five years. The Companys estimated
liability for these costs of $916,000 at February 29, 2016 and May 31, 2015, measured on an undiscounted basis over an estimated period of 15 years; $50,000 of the liability is recorded within current liabilities and the remainder is recorded
within other long-term liabilities in the consolidated balance sheet.
The Company is subject to certain legal and other proceedings in the normal course
of business that, in the opinion of management, should not have a material effect on its future results of operations or financial position.
10. STOCK PURCHASE
In December 2008, the Companys Board of Directors authorized a program to purchase, subject to market conditions, up to 1,125,000
shares of the Companys common stock. As of February 29, 2016, 112,026 cumulative shares had been purchased in negotiated and open market transactions for a total price, including commissions, of approximately $923,000. Shares purchased under
the program were retired. There have been no purchases in fiscal 2016 and there were none in fiscal 2015.
11
PART I FINANCIAL INFORMATION